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Other Considerations 
A Summary of the Status of De Novo Cancer 
in Transplant Recipients 
By Israel Penn and Thomas E. Starzl 
I N 1968 an informal registry was started in Denver to record all tumors which 
occurred in organ homograft recipients, 
including preexisting malignancies, inad-
vertently transplanted tumors, and lesions 
arising de novo after transplantation. Phy-
sicians from transplant centers throughout 
the world have generously contributed 
data concerning their patients. The presen~ 
report deals with cases recorded up till 
May, 1972. 
CLINICAL OBSERVATIONS 
Ninety-three patients developed 9S ma-
lignancies. There were 91 and two reci-
pients of renal and cardiac homografts, 
respectively. Data concerning the cases are 
summarized in Tables 1 and 2. 
Incidence 
Up to the spring of 1972, 9131 renal 
and 189 cardiac homografts had been re-
corded by the ACS-NIH organ transplant 
registry. Because these figures and those 
regarding the number of tumors reported 
are incomplete it is not possible to calcu-
late accurately the incidence of malig-
nancies from these statistics. However, data 
from the renal transplant program at the 
University of Colorado Medical Center and 
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the Denver Veterans Administration Hos-
pital do provide accurate figures. Of 366 
patients who received their transplants 
from 6 mo to 91/2 yr ago, 18 developed 
tumors, an incidence of 4.9%. Without 
making any correction for patients who 
died very soon after transplantation (be-
fore exposure to the hazard under dis-
cussion), the risk of developing cancer is 
thus about 80 times greater than in the 
general population in the same age range. 
Type of Tumors 
Of the 9S tumors S9 (62%) were of 
epithelial origin and 36 (38%) were mesen-
chymal. The most common lesions were 
reticulum cell sarcomas (21 cases, 22%), 
various forms of skin cancer (20 cases, 
21 %), in situ carcinoma of the cervix 
( eight cases, 8 % ), carcinoma of the lip 
(eight cases, 8%) and a variety of lym-
phomas (seven cases, 7%). A wide spec-
trum of other tumors are listed in Table 
1 and 2. 
Two patients each presented with two 
varieties of tumor. One had a reticulum 
cell sarcoma of the brain and Kaposi's 
sarcoma of the skin. The other had a dif-
ferentiated adenocarcinoma of the pan-
creas and a markedly anaplastic carcinoma 
in the mediastinum which may possibly 
have been an intramediastinal seminoma. 
This paper confirms the findings re-
ported in previous publicationsl -3 concern-
ing the remarkable predilection of the lvm-
phomas, and, in particular, the reticulum 
cell sarcomas to involve the central nervous 
system. Of 30 patients with various types 
of lymphoma the brain or spinal cord was 
involved in 14 instances and in 11 cases 
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these were the only organs affected by 
the tumor. 
Age of Patients 
More tumors in patients over the age 
of 40 yr have recently been reported to 
the Denver registry. Nevertheless, the 
affected population is basically a young 
one with an average age of 35 yr (range 
8-64 yr). The epithelial tumors appeared 
at an average age of 36.5 yr and mesen-
chymal lesions at 32 yr. More patients 
with epithelial tumors (40%) were over 
the age of 40 yr than in the case of the 
mesenchymal lesions (17%). 
Time of Appearance of Tumors 
The average time of appearance of the 
tumors after transplantation was 30 mo, 
with the epithelial lesions manifesting at 
33 mo and the mesenchymal malignancies 
at 22 mo. Lymphomas involving the central 
nervous system appeared even earlier at 
an average of 14 mo after transplantation. 
In a previous report4 we drew attention 
to a group of lesions that were diagnosed 
in less than 4 mo after transplantation. 
In the present series, 11 of 93 cases (12%) 
fell into this category, eight with epithelial 
lesions and three with mesenchymal tumors 
(Tables 1 and 2). A reasonable explanation 
could be that at least some of these cases 
or even some of those with a later appear-
ance were already present at the time of 
transplantation. The hypothesis could hold 
that they were small and could not be 
detected but grew rapidly under the in-
fluence of the immunosuppressive therapy. 
In turn, it could be proposed that such 
preexisting tumors were present in in-
creased numbers pretransplantation in con-
sequence of prior chronic renal failure and 
by virtue of the well-recognized depression 
of immune responses that occur in uremia. 
Evidence consistent with but not proving 
this latter hypothesis is cited in a recent 
publication.4 In any event, the most im-
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portant factor in posttransplantation neo-
plasia is clearly not preexisting uremia but 
rather the imposition of posttransplanta-
tion immunosuppression. 
Immunosuppressive Measures 
Tables 1 and 2 summarize immunosup-
pressive measures. All 93 patients received 
prednisone or some form of corticosteroid 
therapy. Ninety-two received azathioprine 
and one was given the related compound 
6-mercaptopurine. Only 25 of the recipients 
were treated with ALG, and in two in-
stances treatment with this agent was 
started after the appearance of the tumors. 
Thiry-five patients underwent splenectomy, 
five thymectomy, two thymic irradiation, 
five thoracic duct fistula construction, and 
one total-body irradiation. 
Possibility of Transmission of 
Tumor from Donor 
There were 105 donors of whom 58 were 
cadavers, 44 living-related volunteers, and 
three living-unrelated donors. All the live 
donors were free of malignant disease and 
have remained so. Two cadaver donors had 
medulloblastomas but their recipients de-
veloped presumably unrelated tumors, a 
reticulum cell sarcoma of the buttock, and 
a leiomyosarcoma of the stomach, respec-
tively. Another cadaver donor had had a 
carcinoma of the colon resected 5 yr pre-
viously but there was no evidence of resi-
dual tumor at the time of transplantation. 
The recipient developed a reticulum cell 
sarcoma. 
Known Preexisting Malignancies 
in the Recipient 
Three of the patients who developed 
de novo malignancies posttransplantation 
had either known tumors before or at the 
time of operation. Two were found to 
have incidental renal carcinomas when 
their diseased native kidneys were re-
moved. One of these patients subsequently 
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developed a reticulum cell sarcoma of the 
brain, and the other had the gastric leio-
myosarcoma mentioned above. Neither had 
any evidence of the original renal neoplasm 
at autopsy. A third recipient, who devel-
oped a new skin cancer after transplanta-
tion, died 18 mo later of metastases of a 
transitional cell carcinoma of the ureter 
which had been resected 2 wk before trans-
plantation. 
Prognosis of Patients with 
De Novo Malignancies 
Thirty-seven of the 93 patients are cur-
rently alive. Patients with mesenchymal 
tumors had the worst prognosis and only 
three of 35 are alive. The outcome of reci-
pients with epithelial malignancies was 
better: 34 of 58 are still living. Most of 
these had low grade malignancies involv-
ing the skin, cervix uteri, or lip, whereas 
those with carcinomas of the thoracic or 
abdominal organs had a poor outlook. 
DISCUSSION 
The chronic use of immunosuppressive 
agents has been associated with an in-
creased incidence of both mesenchymal 
and epithelial malignancies. Surprisingly, 
almost all these tumors have been solid. 
Some patients have manifested transient 
leukemoid reactions but only one case of 
frank leukemia has been recorded to date. 
Even in this case the immunosuppressive 
drugs may not have been responsible as 
the patient was subjected to total-body 
irradiation, which is well recognized as a 
cause of leukemia. 
The present study again emphasizes that 
a number of malignancies, usually asso-
ciated with the older age groups, are being 
encountered in transplant recipients at a 
younger age. This particularly applies to 
several of the more commonly encountered 
tumors in this series such as skin cancers 
and neoplasms of the lip, which are ordi-
narily uncommon under age 40 yr. Reticu-
731 
lum cell sarcomas, which naturally tend 
to occur somewhat earlier in life, are found 
at an even younger average age under 
the influence of immunosuppression. 
The true incidence of neoplasia in trans-
plant patients can only be found in very 
carefully studied series such as our own. 
For registry collections, however, probably 
many of the low grade tumors are being 
missed or dismissed as unimportant, and 
only the more serious lesions reported. 
The fact that 19 of 95 cases recorded in 
the registry are from our own center re-
flects our keen awareness of the frequency 
of this problem as well as the large number 
of long-term followups that we have accu-
mulated. In our center, any suspicious 
lesion of the skin, lip, or uterine cervix 
is biopsied and studied microscopically. 
A diagnostic problem with the skin can-
cers is that warts are extremely common 
in transplant recipients and frequently in-
volve the same exposed areas as do skin 
cancers. Consequently, the tumors are 
likely to be misdiagnosed as common warts. 
By performing numerous and repeated 
biopsies of suspicious lesions we have 
found that the skin cancers are often mul-
tiple and that extensive areas of skin may 
be the seat of either frank malignancy or, 
of intraepithelial cancer (Bowen's disease). 
Similarly, biopsies of areas of persistent 
ulceration of the lip have uncovered carci-
nomas which are often superficial and do 
not present the classical features of an 
indurated base and a rolled everted edge. 
Dysplasia of the epithelium of the cervix 
uteri is not uncommon in normal women 
and it probably occurs with increased fre-
quency under immunosuppression. Con-
sequently, it is not surprising that 8% 
of the patients in the collected series of 
de novo tumors carried the diagnosis of 
in situ carcinomas of the cervix uteri. The 
incidence is probably even higher as many 
cases are not diagnosed unless routine 
cervical smears are done on all female 
732 
organ transplant recipients before opera-
tion and at regular intervals thereafter. 
Neoplasms of the skin, lip, and uterine 
cervix can be successfully treated using 
standard surgical or radiotherapeutic tech-
niques without any alteration in immuno-
suppressive therapy. However, in view of 
the virtually hopeless prognosis with the 
more malignant tumors it may be advisable 
to reduce drastically or even discontinue 
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the immunosuppressive therapy in these 
cases. The three surviving patients with 
mesenchymal tumors were all treated in 
this manner and two other patients with 
high grade malignancies who were similarly 
treated and who died of other causes some 
months after cessation of immunosuppres-
sion were found at autopsy to be free of 
the previously widespread neoplasms. 
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